Concepedia

Author

Masahiro Takita

Kindai UniversityORCID

Also Known As

M Takita, M. Takita, M., Takita, Mao Takita, Masahiro Takita, Takita, M.

214

Publications

3.1K

Citations

31

H-Index

41

Concepts

All Affiliations

Kindai UniversityNational Cancer Center Hospital EastMusashino Red Cross HospitalChiba Cancer CenterTakamatsu Red Cross Hospital
MT

About

Masahiro Takita is an author at Kindai University specializing in medicine, cancer research, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

305

2

Health Sciences

4

4

343

3

Hepatology

2

2

54

4

Engineering

1

1

91

5

Cell Biology

1

1

198

Masahiro Takita

×

56

Publications

2.9K

Citations

31

H-Index

YearCitations

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study

Masatoshi Kudo, Kazuomi Ueshima, Stephan Chan,

Cancers

2019

291

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

Tadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami,

Liver Cancer

2015

203

Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma

Hideki Makinoshima, Masahiro Takita, Shingo Matsumoto,

Journal of Biological Chemistry

2014

198

Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma

Hideki Makinoshima, Masahiro Takita, Koichi Saruwatari,

Journal of Biological Chemistry

2015

184

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study

Kazuomi Ueshima, Naoshi Nishida, Satoru Hagiwara,

Cancers

2019

140

Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study

Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima,

Liver Cancer

2023

127

Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Kazuomi Ueshima, Sadahisa Ogasawara, Masafumi Ikeda,

Liver Cancer

2020

110

Reactive Oxygen Species Induce Epigenetic Instability through the Formation of 8-Hydroxydeoxyguanosine in Human Hepatocarcinogenesis

Naoshi Nishida, Tadaaki Arizumi, Masahiro Takita,

Digestive Diseases

2013

108

Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma

Kazuomi Ueshima, Masatoshi Kudo, Masahiro Takita,

Oncology

2010

102

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT

Tatsuo Inoue, Masatoshi Kudo, Mina Komuta,

Journal of Gastroenterology

2012

91

Page 1